Back to article: Characterising glycosaminoglycans in human breastmilk and their potential role in infant health


FIGURE 1: Percentage change of bioactive components in breastmilk from colostrum (1-4 days pp) compared to mature breastmilk (>15 days pp) 3, 4, 5, 6.

 

3. Coppa G V, Gabrielli O, Bertino E, Zampini L, Galeazzi T, Padella L, Santoro L, Marchesiello R L, Galeotti F, Maccari F, Volpi N (2013). Human milk glycosaminoglycans: the state of the art future perspectives. Ital J Pediatr 39. doi: 10.1186/1824-7288-39-2

4. Lewis-Jones D I, Lewis-Jones M S, Connolly R C, Lloyd D C, West C (1985). Sequential Changes in the Antimicrobial Protein Concentrations in Human Milk during Lactation and Its Relevance to Banked Human Milk. Pediatr Res 19: 561–565.<> doi: 10.1203/00006450-198506000-00012

5. Thum C, Wall C R, Weiss G A, Wang W, Szeto I M-Y, Day L (2021). Changes in HMO Concentrations throughout Lactation: Influencing Factors, Health Effects and Opportunities. Nutrients 13(7): 2272. doi: 10.3390/nu13072272

6. Aydin S, Aydin S, Ozkan Y, Kumru S (2006). Ghrelin is present in human colostrum, transitional and mature milk. Peptides 27(4): 878–882. doi: 10.1016/j.peptides.2005.08.006

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close